ACADIA Pharmaceuticals Inc. earnings per share and revenue

ACAD earnings per share for the last quarter are 0.11 USD whereas the estimation was 0.09 USD which accounts for 26.93% surprise. Company revenue for the same period amounts to 244.32 M USD despite the estimated figure of 238.77 M USD. Estimated earnings per share for the next quarter are 0.14 USD, and revenue is expected to reach 263.46 M USD. Also watch annual changes over time to get a bigger picture of ACAD earnings per share and revenue dynamics.